• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Molecular Mechanisms of Class B GPCR Activation: Insights from Adrenomedullin Receptors.B类G蛋白偶联受体激活的分子机制:来自肾上腺髓质素受体的见解
ACS Pharmacol Transl Sci. 2020 Feb 26;3(2):246-262. doi: 10.1021/acsptsci.9b00083. eCollection 2020 Apr 10.
2
Receptor activity-modifying protein dependent and independent activation mechanisms in the coupling of calcitonin gene-related peptide and adrenomedullin receptors to Gs.降钙素基因相关肽和肾上腺髓质素受体与Gs偶联中依赖和不依赖受体活性修饰蛋白的激活机制
Biochem Pharmacol. 2017 Oct 15;142:96-110. doi: 10.1016/j.bcp.2017.07.005. Epub 2017 Jul 11.
3
Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor: implications for adrenomedullin and calcitonin gene-related peptide pharmacology.受体活性修饰蛋白依赖性突变对降钙素受体样受体的影响:对肾上腺髓质素和降钙素基因相关肽药理学的影响。
Br J Pharmacol. 2014 Feb;171(3):772-88. doi: 10.1111/bph.12508.
4
Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins.通过连接的 RAMP-降钙素受体样受体细胞外域融合蛋白对 CGRP 和肾上腺髓质素肽的选择性结合。
Protein Sci. 2013 Dec;22(12):1775-85. doi: 10.1002/pro.2377. Epub 2013 Oct 19.
5
Receptor Activity-modifying Proteins 2 and 3 Generate Adrenomedullin Receptor Subtypes with Distinct Molecular Properties.受体活性修饰蛋白2和3产生具有不同分子特性的肾上腺髓质素受体亚型。
J Biol Chem. 2016 May 27;291(22):11657-75. doi: 10.1074/jbc.M115.688218. Epub 2016 Mar 24.
6
The third extracellular loop of the human calcitonin receptor-like receptor is crucial for the activation of adrenomedullin signalling.人类降钙素受体样受体的第三个细胞外环对于肾上腺髓质素信号的激活至关重要。
Br J Pharmacol. 2012 May;166(1):137-50. doi: 10.1111/j.1476-5381.2011.01803.x.
7
Adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin G protein-coupled receptor.肾上腺髓质素 2/中介素是一种缓失活、长效的肾上腺髓质素 G 蛋白偶联受体内源性激动剂。
J Biol Chem. 2023 Jun;299(6):104785. doi: 10.1016/j.jbc.2023.104785. Epub 2023 May 4.
8
Structure-function analyses reveal a triple β-turn receptor-bound conformation of adrenomedullin 2/intermedin and enable peptide antagonist design.结构-功能分析揭示了肾上腺髓质素 2/中介素的三 β-转角受体结合构象,并能够设计肽类拮抗剂。
J Biol Chem. 2018 Oct 12;293(41):15840-15854. doi: 10.1074/jbc.RA118.005062. Epub 2018 Aug 23.
9
Probing the Mechanism of Receptor Activity-Modifying Protein Modulation of GPCR Ligand Selectivity through Rational Design of Potent Adrenomedullin and Calcitonin Gene-Related Peptide Antagonists.通过合理设计强效肾上腺髓质素和降钙素基因相关肽拮抗剂探究受体活性修饰蛋白对 G 蛋白偶联受体配体选择性的调控机制。
Mol Pharmacol. 2018 Apr;93(4):355-367. doi: 10.1124/mol.117.110916. Epub 2018 Jan 23.
10
Calcitonin and Amylin Receptor Peptide Interaction Mechanisms: INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS.降钙素与胰淀素受体肽相互作用机制:深入了解受体活性修饰蛋白对降钙素受体的肽结合模式及变构调节
J Biol Chem. 2016 Apr 15;291(16):8686-700. doi: 10.1074/jbc.M115.713628. Epub 2016 Feb 19.

引用本文的文献

1
Bioinformatic RNA-Seq Functional Profiling of the Tumor Suppressor Gene OPCML in Ovarian Cancers: The Multifunctional, Pleiotropic Impacts of Having Three Ig Domains.卵巢癌中肿瘤抑制基因OPCML的生物信息学RNA测序功能分析:拥有三个免疫球蛋白结构域的多功能、多效性影响
Curr Issues Mol Biol. 2025 May 29;47(6):405. doi: 10.3390/cimb47060405.
2
Extracellular bimolecular fluorescence complementation for investigating membrane protein dimerization: a proof of concept using class B GPCRs.用于研究膜蛋白二聚化的细胞外双分子荧光互补:使用 B 类 GPCR 的概念验证。
Biosci Rep. 2024 Oct 30;44(10). doi: 10.1042/BSR20240449.
3
Variable CGRP family peptide signaling durations and the structural determinants thereof.可变的 CGRP 家族肽信号持续时间及其结构决定因素。
Biochem Pharmacol. 2024 Jun;224:116235. doi: 10.1016/j.bcp.2024.116235. Epub 2024 Apr 24.
4
Cryo-EM Structure of the Human Amylin 1 Receptor in Complex with CGRP and Gs Protein.人胰淀素 1 受体与 CGRP 和 Gs 蛋白复合物的冷冻电镜结构。
Biochemistry. 2024 May 7;63(9):1089-1096. doi: 10.1021/acs.biochem.4c00114. Epub 2024 Apr 11.
5
Clinical Potential of Adrenomedullin Signaling in the Cardiovascular System.心血管系统中肾上腺髓质素信号的临床潜力。
Circ Res. 2023 Apr 28;132(9):1185-1202. doi: 10.1161/CIRCRESAHA.123.321673. Epub 2023 Apr 27.
6
Shared and independent roles of CGRP and PACAP in migraine pathophysiology.降钙素基因相关肽(CGRP)和垂体腺苷酸环化酶激活肽(PACAP)在偏头痛发病机制中的共享和独立作用。
J Headache Pain. 2023 Apr 3;24(1):34. doi: 10.1186/s10194-023-01569-2.
7
Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins.阐明 G 蛋白偶联受体和受体活性修饰蛋白的相互作用组。
Pharmacol Rev. 2023 Jan;75(1):1-34. doi: 10.1124/pharmrev.120.000180. Epub 2022 Dec 8.
8
Adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin G protein-coupled receptor.肾上腺髓质素2/中间介质是一种解离速率慢、作用时间长的肾上腺髓质素G蛋白偶联受体内源性激动剂。
bioRxiv. 2023 Jan 13:2023.01.13.523955. doi: 10.1101/2023.01.13.523955.
9
CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond.降钙素基因相关肽的生理学、药理学和治疗靶点:偏头痛及其他。
Physiol Rev. 2023 Apr 1;103(2):1565-1644. doi: 10.1152/physrev.00059.2021. Epub 2022 Dec 1.
10
Determining the Effects of Differential Expression of GRKs and β-arrestins on CLR-RAMP Agonist Bias.确定GRKs和β-抑制蛋白差异表达对CLR-RAMP激动剂偏向性的影响。
Front Physiol. 2022 Mar 29;13:840763. doi: 10.3389/fphys.2022.840763. eCollection 2022.

本文引用的文献

1
Structure and Dynamics of Adrenomedullin Receptors AM and AM Reveal Key Mechanisms in the Control of Receptor Phenotype by Receptor Activity-Modifying Proteins.肾上腺髓质素受体AM和AM的结构与动力学揭示了受体活性修饰蛋白控制受体表型的关键机制。
ACS Pharmacol Transl Sci. 2020 Mar 20;3(2):263-284. doi: 10.1021/acsptsci.9b00080. eCollection 2020 Apr 10.
2
Deconvoluting the Molecular Control of Binding and Signaling at the Amylin 3 Receptor: RAMP3 Alters Signal Propagation through Extracellular Loops of the Calcitonin Receptor.解析胰淀素3受体结合与信号传导的分子调控:RAMP3通过降钙素受体的细胞外环改变信号传导
ACS Pharmacol Transl Sci. 2019 Mar 18;2(3):183-197. doi: 10.1021/acsptsci.9b00010. eCollection 2019 Jun 14.
3
The Molecular Control of Calcitonin Receptor Signaling.降钙素受体信号传导的分子调控
ACS Pharmacol Transl Sci. 2019 Jan 11;2(1):31-51. doi: 10.1021/acsptsci.8b00056. eCollection 2019 Feb 8.
4
Molecular Signature for Receptor Engagement in the Metabolic Peptide Hormone Amylin.代谢肽激素胰淀素受体结合的分子特征
ACS Pharmacol Transl Sci. 2018 Apr 23;1(1):32-49. doi: 10.1021/acsptsci.8b00002. eCollection 2018 Sep 14.
5
Pharmacological Characterization and Investigation of N-Terminal Loop Amino Acids of Adrenomedullin 2 That Are Important for Receptor Activation.药理学特征分析及对 AM2 受体激活中 N 端环氨基酸的研究
Biochemistry. 2019 Aug 13;58(32):3468-3474. doi: 10.1021/acs.biochem.9b00571. Epub 2019 Jul 29.
6
Shear stress-induced endothelial adrenomedullin signaling regulates vascular tone and blood pressure.切应力诱导的内皮素肾上腺髓质素信号调节血管张力和血压。
J Clin Invest. 2019 Jun 17;129(7):2775-2791. doi: 10.1172/JCI123825.
7
Substituted Pyridazin-3(2 H)-ones as Highly Potent and Biased Formyl Peptide Receptor Agonists.取代哒嗪-3(2H)-酮作为高效和偏倚的甲酰肽受体激动剂。
J Med Chem. 2019 May 23;62(10):5242-5248. doi: 10.1021/acs.jmedchem.8b01912. Epub 2019 May 13.
8
Circulating Biologically Active Adrenomedullin Predicts Organ Failure and Mortality in Sepsis.循环生物活性肾上腺髓质素预测脓毒症器官衰竭和死亡。
Ann Lab Med. 2019 Sep;39(5):454-463. doi: 10.3343/alm.2019.39.5.454.
9
Structure and dynamics of the active human parathyroid hormone receptor-1.人甲状旁腺激素受体-1 的结构与动力学。
Science. 2019 Apr 12;364(6436):148-153. doi: 10.1126/science.aav7942.
10
Biased Receptor Signaling in Drug Discovery.药物发现中的偏向性受体信号转导
Pharmacol Rev. 2019 Apr;71(2):267-315. doi: 10.1124/pr.118.016790.

B类G蛋白偶联受体激活的分子机制:来自肾上腺髓质素受体的见解

Molecular Mechanisms of Class B GPCR Activation: Insights from Adrenomedullin Receptors.

作者信息

Garelja Michael L, Au Maggie, Brimble Margaret A, Gingell Joseph J, Hendrikse Erica R, Lovell Annie, Prodan Nicole, Sexton Patrick M, Siow Andrew, Walker Christopher S, Watkins Harriet A, Williams Geoffrey M, Wootten Denise, Yang Sung H, Harris Paul W R, Hay Debbie L

机构信息

School of Biological Sciences, University of Auckland, Auckland, 1010, New Zealand.

Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland, 1010, New Zealand.

出版信息

ACS Pharmacol Transl Sci. 2020 Feb 26;3(2):246-262. doi: 10.1021/acsptsci.9b00083. eCollection 2020 Apr 10.

DOI:10.1021/acsptsci.9b00083
PMID:32296766
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7155197/
Abstract

Adrenomedullin (AM) is a 52 amino acid peptide that plays a regulatory role in the vasculature. Receptors for AM comprise the class B G protein-coupled receptor, the calcitonin-like receptor (CLR), in complex with one of three receptor activity-modifying proteins (RAMPs). The C-terminus of AM is involved in binding to the extracellular domain of the receptor, while the N-terminus is proposed to interact with the juxtamembranous portion of the receptor to activate signaling. There is currently limited information on the molecular determinants involved in AM signaling, thus we set out to define the importance of the AM N-terminus through five signaling pathways (cAMP production, ERK phosphorylation, CREB phosphorylation, Akt phosphorylation, and IP production). We characterized the three CLR:RAMP complexes through the five pathways, finding that each had a distinct repertoire of intracellular signaling pathways that it is able to regulate. We then performed an alanine scan of AM from residues 15-31 and found that most residues could be substituted with only small effects on signaling, and that most substitutions affected signaling through all receptors and pathways in a similar manner. We identify F18, T20, L26, and I30 as being critical for AM function, while also identifying an analogue (AM G19A) which has unique signaling properties relative to the unmodified AM. We interpret our findings in the context of new structural information, highlighting the complementary nature of structural biology and functional assays.

摘要

肾上腺髓质素(AM)是一种由52个氨基酸组成的肽,在脉管系统中发挥调节作用。AM的受体包括B类G蛋白偶联受体、降钙素样受体(CLR),它与三种受体活性修饰蛋白(RAMP)之一形成复合物。AM的C末端参与与受体细胞外结构域的结合,而N末端则被认为与受体的近膜部分相互作用以激活信号传导。目前关于AM信号传导所涉及的分子决定因素的信息有限,因此我们着手通过五条信号通路(cAMP产生、ERK磷酸化、CREB磷酸化、Akt磷酸化和IP产生)来确定AM N末端的重要性。我们通过这五条通路对三种CLR:RAMP复合物进行了表征,发现每种复合物都有一套独特的能够调节的细胞内信号通路。然后我们对AM的15 - 31位残基进行了丙氨酸扫描,发现大多数残基被取代时对信号传导的影响很小,并且大多数取代以类似的方式影响所有受体和通路的信号传导。我们确定F18、T20、L26和I30对AM功能至关重要,同时还鉴定出一种类似物(AM G19A),其相对于未修饰的AM具有独特的信号特性。我们结合新的结构信息来解释我们的发现,突出了结构生物学和功能测定的互补性质。